» Articles » PMID: 28669750

EMT Transcription Factors in Cancer Development Re-evaluated: Beyond EMT and MET

Overview
Publisher Elsevier
Date 2017 Jul 4
PMID 28669750
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Reactivation of an embryonic epithelial-to-mesenchymal (EMT) program is commonly accepted as a core component of carcinoma progression. Collectively, EMT and transcription factors (EMT-TFs) of the ZEB, SNAIL and TWIST families are quoted in the same breath for nearly 20years. Recent work on these EMT-TFs has extended their scope, and their typical definition as EMT-inducing factors has become out-of-date. New insights have warranted a re-evaluation of these transcription factors and their pleiotropic functions in physiological and pathological conditions, not solely limited to cell invasion and dissemination.

Citing Articles

Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways.

Meng Q, Li Z, He X, Hu Y, Wu G, Huang J Front Pharmacol. 2025; 16:1496511.

PMID: 39989901 PMC: 11842333. DOI: 10.3389/fphar.2025.1496511.


Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting restorative regimens.

Famta P, Shah S, Dey B, Kumar K, Bagasariya D, Vambhurkar G Cancer Pathog Ther. 2025; 3(1):30-47.

PMID: 39872366 PMC: 11764040. DOI: 10.1016/j.cpt.2024.01.001.


Smad2 Cooperating with TGIF2 Contributes to EMT and Cancer Stem Cells Properties in Pancreatic Cancer via Co-Targeting SOX2.

Zu F, Chen C, Geng Q, Li H, Chan B, Luo G Int J Biol Sci. 2025; 21(2):524-543.

PMID: 39781447 PMC: 11705628. DOI: 10.7150/ijbs.102381.


miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1.

Choi J, Seok H, Lee D, Kwon J, Shin U, Shin I J Transl Med. 2024; 22(1):980.

PMID: 39472937 PMC: 11523791. DOI: 10.1186/s12967-024-05797-1.


Circulating tumor cells in pancreatic cancer: more than liquid biopsy.

Li Z, Qin C, Zhao B, Li T, Zhao Y, Zhang X Ther Adv Med Oncol. 2024; 16:17588359241284935.

PMID: 39421679 PMC: 11483845. DOI: 10.1177/17588359241284935.